Dennis Hernandez

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro

Steven M. LeVine, Dennis Hernandez, Gregory Yamanaka et al. · Antimicrobial Agents and Chemotherapy · 2002 · 192 citations · Full text

Viral Replication, Chronic Hbv Infections, Viral Hepatitis +15

Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)

Fiona McPhee, Amy K. Sheaffer, Jacques Friborg et al. · Antimicrobial Agents and Chemotherapy · 2012 · 183 citations · Full text

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

Yoshiyasu Karino, Joji Toyota, Kenji Ikeda et al. · Journal of Hepatology · 2012 · 165 citations

Molecular Virology, Hepatitis C, Direct-acting Antivirals Daclatasvir +8

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

Stanislas Pol, Reem Ghalib, Vinod K. Rustgi et al. · The Lancet Infectious Diseases · 2012 · 147 citations

Hepatology, Hepatitis C, Viral Hepatitis +6